Amy Pasley

Amy Pasley serves as the Global Platform Director for Nucleic Acid Delivery at Croda since January 2024. Previously, Amy held the position of Head Global Nucleic Acid Therapeutics at Catalent Pharma Solutions from 2021 to 2023, where responsibilities included defining business strategy and managing financial performance for the nucleic acid therapeutics segment. Prior experience includes roles at Thermo Fisher Scientific, where Amy achieved significant revenue growth, and positions in marketing and business development across various companies, including American International Chemical and Atos Medical. Amy Pasley also founded AMP Consulting, providing marketing resources for businesses, and began a research career at the University of Iowa, focusing on glucose transporter proteins. Education includes a Bachelor of Science in Bacteriology from the University of Wisconsin-Madison.